[Is the use of beta receptor blockers in variously strong concentrations in the treatment of glaucoma sensible?].
Beta-adrenergic blocking agents are usually administered in 2 or 3 different concentrations in the treatment of glaucoma. Arguments for varying the dose are dose-dependent decompression, the onset of symptoms similar to tachyphylaxis, and the incidence of systemic side-effects which may be influenced by modification of the dose. The present author's results, however, appear to contradict these arguments; therefore, this paper discusses whether there is any advantage to be gained by administering beta blockers in different concentrations.
D004305:Dose-Response Relationship, Drug; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D010869:Pindolol / Q000009:adverse effects / Q000627:therapeutic use*; D012306:Risk; D013999:Timolol / Q000009:adverse effects / Q000627:therapeutic use*
D013999:Timolol; D010869:Pindolol
Ist die Verwendung von beta-Rezeptoren-Blockern in verschieden starken Konzentrationen bei der Behandlung des Glaukoms sinnvoll?